rs184127567
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_021971.4(GMPPB):c.1048G>A(p.Gly350Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000323 in 1,610,778 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_021971.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GMPPB | NM_021971.4 | c.1048G>A | p.Gly350Ser | missense_variant | 9/9 | ENST00000308388.7 | NP_068806.2 | |
GMPPB | NM_013334.4 | c.1129G>A | p.Gly377Ser | missense_variant | 8/8 | NP_037466.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GMPPB | ENST00000308388.7 | c.1048G>A | p.Gly350Ser | missense_variant | 9/9 | 1 | NM_021971.4 | ENSP00000311130 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000282 AC: 43AN: 152248Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00123 AC: 305AN: 248056Hom.: 0 AF XY: 0.000953 AC XY: 128AN XY: 134320
GnomAD4 exome AF: 0.000328 AC: 479AN: 1458412Hom.: 2 Cov.: 32 AF XY: 0.000311 AC XY: 226AN XY: 725688
GnomAD4 genome AF: 0.000269 AC: 41AN: 152366Hom.: 1 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74510
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 22, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
GMPPB-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 25, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14;C3809221:Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14;C4518000:Autosomal recessive limb-girdle muscular dystrophy type 2T Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at